CMS plans to push again the beginning of the Radiation Oncology mannequin to July 1, the company stated Wednesday.
The experimental cost mannequin was scheduled to start Jan. 1. However CMS stated it might delay it after a number of stakeholders informed the company it might be too tough to place into observe by the start of subsequent yr.
The radiation oncology mannequin is meant to check whether or not making 90-day bundled funds for radiation remedy maintains or improves the standard of care that Medicare beneficiaries obtain and reduces Medicare spending in comparison with conventional fee-for-service. In accordance with CMS, the pilot will save the federal authorities $230 million over 5 years.
CMS thinks sufferers may benefit from fewer therapies and higher outcomes below the brand new cost mannequin.